AMGEN INC
AMGNNASDAQ——
Quote unavailableTrack AMGN
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$235.64B
Large Cap
📈Revenue Growth (YoY)
8.2%
Slowing
📊Gross Margin
74.7%
High
💵FCF Margin
26.1%
Strong
⚖️P/S Ratio
6.1x
Fair
Otter Score
68
Fair
AMGEN INC
AMGNAnalyst Ratings
Total
25
Raised
23
Lowered
2
Avg PT
$445.40
H / L
$542 / $230
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler Amgen | Raised | Overweight | 2026-11-19 | $542.00 | — |
Goldman Sachs Amgen | Raised | Buy | 2026-11-04 | $536.00 | — |
TD Cowen Amgen | Raised | Buy | 2026-11-04 | $531.00 | — |
UBS Amgen | Raised | Buy | 2026-11-04 | $530.00 | — |
Scotiabank Amgen | Raised | Sector Outperform | 2026-11-04 | $530.00 | — |
Argus Research Amgen | Raised | Buy | 2026-11-12 | $515.00 | — |
Oppenheimer Amgen | Raised | Outperform | 2026-10-23 | $480.00 | — |
Freedom Broker Amgen | Raised | Buy → Hold | 2026-11-06 | $470.00 | — |
RBC Capital Amgen | Raised | Outperform | 2026-11-04 | $470.00 | — |
Citigroup Amgen | Raised | Neutral | 2026-11-04 | $465.00 | — |
Cantor Fitzgerald Amgen | Raised | Neutral | 2026-11-04 | $465.00 | — |
Leerink Partners Amgen | Raised | Market Perform | 2026-11-05 | $464.00 | — |
Wells Fargo Amgen | Raised | Equal-Weight | 2026-11-04 | $460.00 | — |
Canaccord Genuity Amgen | Raised | Hold | 2026-11-04 | $440.00 | — |
Guggenheim Amgen | Raised | Neutral | 2026-11-05 | $435.00 | — |
Barclays Amgen | Raised | Equal-Weight | 2026-11-16 | $430.00 | — |
JP Morgan Amgen | Raised | Neutral | 2026-11-04 | $425.00 | — |
HSBC Amgen | Lowered | Buy → Hold | 2026-09-10 | $425.00 | — |
BMO Capital Amgen | Lowered | Market Perform | 2026-10-12 | $415.00 | — |
Morgan Stanley Amgen | Raised | Equal-Weight | 2026-11-04 | $410.00 | — |
Bernstein Amgen | Raised | Market Perform | 2026-11-04 | $400.00 | — |
Truist Securities Amgen | Raised | Hold | 2026-11-04 | $398.00 | — |
Mizuho Amgen | Raised | Neutral | 2026-08-18 | $352.00 | — |
B of A Securities Amgen | Raised | Underperform | 2026-08-05 | $317.00 | — |
Baird Amgen | Raised | Underperform | 2026-08-05 | $230.00 | — |
Institution
Piper Sandler
Raised · Overweight · 2026-11-19
$542.00
—
Goldman Sachs
Raised · Buy · 2026-11-04
$536.00
—
TD Cowen
Raised · Buy · 2026-11-04
$531.00
—
UBS
Raised · Buy · 2026-11-04
$530.00
—
Scotiabank
Raised · Sector Outperform · 2026-11-04
$530.00
—
Argus Research
Raised · Buy · 2026-11-12
$515.00
—
Oppenheimer
Raised · Outperform · 2026-10-23
$480.00
—
Freedom Broker
Raised · Buy → Hold · 2026-11-06
$470.00
—
RBC Capital
Raised · Outperform · 2026-11-04
$470.00
—
Citigroup
Raised · Neutral · 2026-11-04
$465.00
—
Cantor Fitzgerald
Raised · Neutral · 2026-11-04
$465.00
—
Leerink Partners
Raised · Market Perform · 2026-11-05
$464.00
—
Wells Fargo
Raised · Equal-Weight · 2026-11-04
$460.00
—
Canaccord Genuity
Raised · Hold · 2026-11-04
$440.00
—
Guggenheim
Raised · Neutral · 2026-11-05
$435.00
—
Barclays
Raised · Equal-Weight · 2026-11-16
$430.00
—
JP Morgan
Raised · Neutral · 2026-11-04
$425.00
—
HSBC
Lowered · Buy → Hold · 2026-09-10
$425.00
—
BMO Capital
Lowered · Market Perform · 2026-10-12
$415.00
—
Morgan Stanley
Raised · Equal-Weight · 2026-11-04
$410.00
—
Bernstein
Raised · Market Perform · 2026-11-04
$400.00
—
Truist Securities
Raised · Hold · 2026-11-04
$398.00
—
Mizuho
Raised · Neutral · 2026-08-18
$352.00
—
B of A Securities
Raised · Underperform · 2026-08-05
$317.00
—
Baird
Raised · Underperform · 2026-08-05
$230.00
—
One row per institution · price target from the firm's latest published target